Suppr超能文献

一项回顾性队列研究:英国一家三级炎症性肠病中心的克罗恩病术前口服肠内营养优化。

A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre.

机构信息

IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Department of Gastroenterology, St George's Hospital, London, UK.

出版信息

Aliment Pharmacol Ther. 2022 Aug;56(4):646-663. doi: 10.1111/apt.17055. Epub 2022 Jun 20.

Abstract

BACKGROUND

Low-quality evidence suggests that pre-operative exclusive enteral nutrition (E/EN) can improve postoperative outcomes in patients with Crohn's disease (CD). It is not standard practice in most centres.

AIMS

To test the hypothesis that pre-operative EN in patients undergoing ileal/ileocolonic surgery for CD is associated with improved postoperative outcome.

METHODS

We performed a single centre retrospective observational study comparing surgical outcomes in patients receiving pre-operative EN (≥600 kcal/day for ≥2 weeks) with those who received no nutritional optimisation. Consecutive adult patients undergoing ileal/ileocolonic resection from 2008 to 2020 were included. The primary outcome was postoperative complications <30 days. Secondary outcomes included EN tolerance, specific surgical complications, unplanned stoma formation, length of stay, length of bowel resected, readmission and biochemical/anthropometric changes.

RESULTS

300 surgeries were included comprising 96 without nutritional optimisation and 204 optimised cases: oral EN n = 173, additional PN n = 31 (4 of whom had received nasogastric/nasojejunal EN). 142/204 (69.6%) tolerated EN. 125/204 (61.3%) initiated EN in clinic. Patients in the optimised cohort were younger at operation and diagnosis, with an increased frequency of penetrating disease and exposure to antibiotics or biologics, and were more likely to undergo laparoscopic surgery. The optimised cohort had favourable outcomes on multivariate analysis: all complications [OR 0.29; 0.15-0.57, p < 0.001], surgical complications [OR 0.41; 95% CI 0.20-0.87, p = 0.02], non-surgical complications [OR 0.24 95% CI 0.11-0.52, p < 0.001], infective complications [OR 0.32; 95% CI 0.16-0.66, p = 0.001].

CONCLUSIONS

Oral EN was reasonably well tolerated and associated with a reduction in 30-day postoperative complications. Randomised controlled trials are required to confirm these findings.

摘要

背景

低质量证据表明,术前肠外营养(E/EN)可改善克罗恩病(CD)患者的术后结局。但在大多数中心,这并非标准做法。

目的

验证假设,即 CD 患者接受回肠/回结肠手术前进行肠内营养(EN),是否与改善术后结果相关。

方法

我们进行了一项单中心回顾性观察性研究,比较接受术前 EN(≥600kcal/天,持续≥2 周)与未进行任何营养优化的患者的手术结局。纳入 2008 年至 2020 年连续接受回肠/回结肠切除术的成年患者。主要结局为术后 30 天内发生的并发症。次要结局包括 EN 耐受情况、特定手术并发症、计划外造口形成、住院时间、切除肠段长度、再入院和生化/人体测量学变化。

结果

共纳入 300 例手术,其中 96 例未进行营养优化,204 例进行了优化:口服 EN 组 n=173,另外给予 PN 组 n=31(其中 4 例曾接受鼻胃/鼻空肠 EN)。204 例患者中有 142 例(69.6%)耐受 EN。204 例患者中有 125 例(61.3%)在门诊开始接受 EN。优化组患者的手术时年龄和诊断时年龄均较小,穿透性疾病发生率较高,且更常接受抗生素或生物制剂治疗,更可能接受腹腔镜手术。多变量分析显示,优化组的结局较好:所有并发症[OR 0.29;0.15-0.57,p<0.001]、手术并发症[OR 0.41;95%CI 0.20-0.87,p=0.02]、非手术并发症[OR 0.24;95%CI 0.11-0.52,p<0.001]、感染性并发症[OR 0.32;95%CI 0.16-0.66,p=0.001]。

结论

口服 EN 耐受性良好,与降低 30 天术后并发症相关。需要开展随机对照试验来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2474/9544188/c604c17f5529/APT-56-646-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验